Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX)

76 filings reported holding PSTX - Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.2M shares of 98.4M outstanding shares and own 26.59% of the company stock.
Largest 10 shareholders include FMR LLC (9.38M shares), Pentwater Capital Management LP (4.97M shares), BlackRock Inc. (2.55M shares), NATIXIS (1.7M shares), VANGUARD GROUP INC (1.45M shares), Aisling Capital Management LP (1.04M shares), MILLENNIUM MANAGEMENT LLC (897K shares), STATE STREET CORP (544K shares), GEODE CAPITAL MANAGEMENT, LLC (491K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (328K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.